This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of July 2025. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.
We do not have any donee information for the donee University of California, San Diego in our system.
| Cause area | Count | Median | Mean | Minimum | 10th percentile | 20th percentile | 30th percentile | 40th percentile | 50th percentile | 60th percentile | 70th percentile | 80th percentile | 90th percentile | Maximum |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall | 38 | 271,207 | 636,829 | 10,000 | 100,000 | 100,000 | 100,000 | 214,720 | 271,207 | 326,700 | 749,760 | 1,001,084 | 1,602,326 | 4,748,025 |
| Developmental Disabilities | 3 | 240,000 | 183,333 | 10,000 | 10,000 | 10,000 | 10,000 | 240,000 | 240,000 | 240,000 | 300,000 | 300,000 | 300,000 | 300,000 |
| Science | 4 | 326,700 | 462,865 | 25,000 | 25,000 | 25,000 | 326,700 | 326,700 | 326,700 | 749,760 | 749,760 | 750,000 | 750,000 | 750,000 |
| Scientific research | 1 | 54,226 | 54,226 | 54,226 | 54,226 | 54,226 | 54,226 | 54,226 | 54,226 | 54,226 | 54,226 | 54,226 | 54,226 | 54,226 |
| Global health | 20 | 137,495 | 806,656 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 137,495 | 342,406 | 857,110 | 1,564,515 | 1,930,642 | 4,748,025 |
| Financing | 2 | 100,000 | 714,175 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 1,328,350 | 1,328,350 | 1,328,350 | 1,328,350 | 1,328,350 |
| Economics | 1 | 113,940 | 113,940 | 113,940 | 113,940 | 113,940 | 113,940 | 113,940 | 113,940 | 113,940 | 113,940 | 113,940 | 113,940 | 113,940 |
| Digital Technology | 1 | 214,720 | 214,720 | 214,720 | 214,720 | 214,720 | 214,720 | 214,720 | 214,720 | 214,720 | 214,720 | 214,720 | 214,720 | 214,720 |
| Energy and Environment | 1 | 271,207 | 271,207 | 271,207 | 271,207 | 271,207 | 271,207 | 271,207 | 271,207 | 271,207 | 271,207 | 271,207 | 271,207 | 271,207 |
| Evidence-Based Policy | 1 | 312,147 | 312,147 | 312,147 | 312,147 | 312,147 | 312,147 | 312,147 | 312,147 | 312,147 | 312,147 | 312,147 | 312,147 | 312,147 |
| Criminal justice reform | 1 | 322,962 | 322,962 | 322,962 | 322,962 | 322,962 | 322,962 | 322,962 | 322,962 | 322,962 | 322,962 | 322,962 | 322,962 | 322,962 |
| Nutrition | 1 | 343,970 | 343,970 | 343,970 | 343,970 | 343,970 | 343,970 | 343,970 | 343,970 | 343,970 | 343,970 | 343,970 | 343,970 | 343,970 |
| Women's equality organisations and institutions | 2 | 1,001,084 | 1,301,705 | 1,001,084 | 1,001,084 | 1,001,084 | 1,001,084 | 1,001,084 | 1,001,084 | 1,602,326 | 1,602,326 | 1,602,326 | 1,602,326 | 1,602,326 |
| Donor | Total | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2007 | 2000 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill and Melinda Gates Foundation (filter this donee) | 20,508,842.00 | 105,882.00 | 4,623,555.00 | 8,981,506.00 | 658,775.00 | 2,274,612.00 | 100,000.00 | 3,264,512.00 | 100,000.00 | 100,000.00 | 300,000.00 | 0.00 | 0.00 |
| Sloan Foundation (filter this donee) | 2,451,327.00 | 0.00 | 1,770,967.00 | 0.00 | 326,700.00 | 0.00 | 0.00 | 353,660.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Arnold Ventures (filter this donee) | 689,335.00 | 0.00 | 0.00 | 635,109.00 | 0.00 | 0.00 | 54,226.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| John Merck Fund (filter this donee) | 550,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 10,000.00 | 0.00 | 0.00 | 300,000.00 | 240,000.00 |
| Total | 24,199,504.00 | 105,882.00 | 6,394,522.00 | 9,616,615.00 | 985,475.00 | 2,274,612.00 | 154,226.00 | 3,618,172.00 | 110,000.00 | 100,000.00 | 300,000.00 | 300,000.00 | 240,000.00 |
There are no documents associated with this donee.
Graph of top 10 donors (for donations with known year of donation) by amount, showing the timeframe of donations
| Donor | Amount (current USD) | Amount rank (out of 38) | Donation date | Cause area | URL | Influencer | Notes |
|---|---|---|---|---|---|---|---|
| Bill and Melinda Gates Foundation | 105,882.00 | 26 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to help evaluate the utility of in vivo monoclonal antibody expression as a therapy for infectious diseases; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,001,084.00 | 8 | Women's equality organisations and institutions | https://iatiregistry.org/publisher/bmgf | -- | to support the development of a Gender Analytics Cell toward generation of high quality analyses of NFHS-4 data on gender outcomes and norms to advance thinking and inform decision-makers at national and sub-national levels; Aid type: Project-type interventions. Affected countries: India. | |
| Bill and Melinda Gates Foundation | 342,406.00 | 15 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to help evaluate the utility of in vivo monoclonal antibody expression as a therapy for infectious diseases; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 137,495.00 | 24 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to identify lead small molecules to treat the neglected tropical disease of schistosomiasis in developing countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,328,350.00 | 7 | Financing/Formal sector financial intermediaries | https://iatiregistry.org/publisher/bmgf | -- | to catalyze the number of school-age children, in particular girls, attending secondary school by providing the rural poor with access to digital financial services for secure payment and recording of school fees.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 27 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to help develop better drugs against the parasite Cryptosporidium, which is a major cause of diarrhea-associated infant deaths in developing countries, by using a genetically-modified yeast strain to identify the target of candidate compounds; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 857,110.00 | 9 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to identify natural compounds in human milk that protect infants from environmental enteric disease and diarrhea; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 857,110.00 | 9 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to identify natural compounds in human milk that protect infants from environmental enteric disease and diarrhea; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Sloan Foundation | 749,760.00 | 12 | Science/Chemistry of Indoor Environments | https://sloan.org/grant-detail/8186 | -- | Grant investigator: Vicki Grassian; to investigate the fundamental chemistry of indoor surfaces. | |
| Sloan Foundation | 750,000.00 | 11 | Science/Microbiology of the Built Environment | https://sloan.org/grant-detail/8204 | -- | Grant investigator: Robin Knight; to develop and disseminate techniques for 3D mapping of the microbiology and metabolism of built environments. | |
| Sloan Foundation | 271,207.00 | 20 | Energy and Environment/ | https://sloan.org/grant-detail/8249 | -- | Grant investigator: David Victor; to assess the economic, policy, institutional, and technological barriers and opportunities associated with the development and deployment of carbon capture, utilization, and sequestration technologies. | |
| Bill and Melinda Gates Foundation | 219,675.00 | 22 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to test three promising drug candidates for the potential to protect newborn babies against brain injury and cerebral palsy using a custom experimental model; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,602,326.00 | 4 | Women's equality organisations and institutions | https://iatiregistry.org/publisher/bmgf | -- | to identify and address gaps in measurement of gender equity and empowerment, supporting best evidence measures for monitoring and evaluation of programs, policies and initiatives designed to improve gender equity and empowerment; Aid type: Project-type interventions. Affected countries: India. | |
| Bill and Melinda Gates Foundation | 4,748,025.00 | 1 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to accelerate the development of new effective antimalarial drugs through the identification of Plasmodium falciparum targets of novel scaffolds via a chemical genomic approach; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 2,411,480.00 | 2 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to develop a point of care biometric device. Kidprint Phase II. Investment start date: 9/22/2016 to end date: 4/30/2019. Grantee name: University of California at San Diego; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Arnold Ventures | 322,962.00 | 17 | Criminal justice reform | https://www.arnoldventures.org/grants/ | -- | To improve the statistical methodology used to evaluate the reliability of eyewitness identification. Affected states: California. | |
| Arnold Ventures | 312,147.00 | 18 | Evidence-Based Policy | https://www.arnoldventures.org/grants/ | -- | To fund a randomized controlled trial of performance incentives for community college instructors and their students. Affected states: California. | |
| Bill and Melinda Gates Foundation | 558,775.00 | 13 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to develop a technology to quickly and accurately capture and classify fingerprints in rural settings and provide unique identification based on the biometric; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 27 | Financing/Formal sector financial intermediaries | https://iatiregistry.org/publisher/bmgf | -- | to promote the use of mobile money in West Africa by enabling the low-cost transfer of money safely and directly from individuals to an institution like a school, along with the generation of receipts and transaction records; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Sloan Foundation | 326,700.00 | 16 | Science/Microbiology of the Built Environment | https://sloan.org/grant-detail/7755 | -- | Grant investigator: Robin Knight; to develop improved software tools for studying the microbiology of the built environment that integrate sequence data, metabolic data, and building science data. | |
| Bill and Melinda Gates Foundation | 1,930,642.00 | 3 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to accelerate the development of new effective antimalarial drugs through the identification of Plasmodium falciparum targets of novel scaffolds via a chemical genomic approach; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 343,970.00 | 14 | Nutrition/basic nutrition | https://iatiregistry.org/publisher/bmgf | -- | to generate knowledge and public communication of learnings to move the child nutrition field forward; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 27 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | To enable the design of effective combinations of next-generation anti-malarials for overcoming drug resistance by classifying anti-malarial drug candidates using a modified yeast strain displaying enhanced drug sensitivity.; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Arnold Ventures | 54,226.00 | 36 | Scientific research/research integrity | https://www.arnoldventures.org/grants/ | -- | To help develop high-quality teachers in the Houston Independent School District in Texas. Affected states: California. | |
| Bill and Melinda Gates Foundation | 1,599,997.00 | 5 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to accelerate the development of new effective antimalarial drugs through the identification of Plasmodium falciparum targets of novel scaffolds via a chemical genomic approach; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 27 | Global health/Reproductive health care | https://iatiregistry.org/publisher/bmgf | -- | to develop wireless tattoo-like electronics to continuously monitor vital signs of the pregnant mother and fetus.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,564,515.00 | 6 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to develop a robust, reproducible set of assays that can be used to identify anti-malarial compounds that prevent the development of gametocytes or have transmission-blocking activities.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Sloan Foundation | 25,000.00 | 37 | Science/ | https://sloan.org/grant-detail/7836 | -- | Grant investigator: Terrence Sejnowski; to provide partial support for the 2012 Sloan-Swartz Annual Meeting on Computational Neuroscience. | |
| Sloan Foundation | 214,720.00 | 23 | Digital Technology/Scholarly Communication | https://sloan.org/grant-detail/6728 | -- | Grant investigator: Philip Bourne; to support a network of practitioners working to transform scholarly communication via online community-building and a "Beyond the PDF 2" workshop. | |
| Sloan Foundation | 113,940.00 | 25 | Economics/Economic Institutions, Behavior, & Performance | https://sloan.org/grant-detail/6822 | -- | Grant investigator: John Skrentny; initiative: Economic Analysis of Science and Technology (EAST); to study training and innovation in the science and engineering workforce. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 27 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to isolate and sequence RNA found in the hair and nails of newborns to uncover nutritional or environmental factors that cause newborn disease.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| John Merck Fund | 10,000.00 | 38 | Developmental Disabilities | https://www.jmfund.org/program-grants/ | -- | Focus: John Merck Scholars I ProgramTo support research on genetic dissection of CNS wiring specificity in development and disease by John Merck Scholar finalist Andrew Huberman. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 27 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to develop a novel delivery system for non-toxic, anti-roundworm proteins. Novel Delivery of Protein Anthelmintics. Investment start date: 11/1/2010 to end date: 4/30/2012. Grantee name: University of California at San Diego; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 27 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to create a humanized mouse in which P. falciparum/vivax complete the life cycle. GCE: Humanized Mouse: Recapitulate P. falciparum/vivax Cycle. Investment start date: 11/1/2009 to end date: 7/31/2011. Grantee name: University of California at San Diego; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 27 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to identify and validate new antigens for natural immune boosting TBV. GCE: Immune Boosting Malaria Transmission Blocking Vaccine (TBV). Investment start date: 11/1/2009 to end date: 6/30/2011. Grantee name: University of California at San Diego; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 27 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to develop and test engineered pseudoviruses called TIPs, which conditionally replicate along with the pathogen as it spreads, but have their virulence elements replaced with therapeutic elements that slow disease progression and transmission.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| John Merck Fund | 300,000.00 | 19 | Developmental Disabilities | https://www.jmfund.org/program-grants/ | -- | Focus: John Merck Scholars I ProgramTo support research to determine the molecular architecture and functional modulation of glutamate receptor complexes; key molecules in cognition, emotion and behavior by John Merck Scholar Terunaga Nakagawa. | |
| John Merck Fund | 240,000.00 | 21 | Developmental Disabilities | https://www.jmfund.org/program-grants/ | -- | Focus: John Merck Scholars I ProgramTo support research on the genetic mechanisms of neuronal migration to the cerebral cortex by John Merck Scholar Joseph Gleeson, MD. |